 MALVERN, Pa., May 21, 2021 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA, a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company plans to participate in two upcoming investor conferences. 